Literature DB >> 11799176

Segregation of CD4 and CXCR4 into distinct lipid microdomains in T lymphocytes suggests a mechanism for membrane destabilization by human immunodeficiency virus.

Susan L Kozak1, Jean Michel Heard, David Kabat.   

Abstract

Recent evidence has suggested that plasma membrane sphingolipids and cholesterol spontaneously coalesce into raft-like microdomains and that specific proteins, including CD4 and some other T-cell signaling molecules, sequester into these rafts. In agreement with these results, we found that CD4 and the associated Lck tyrosine kinase of peripheral blood mononuclear cells and H9 leukemic T cells were selectively and highly enriched in a low-density lipid fraction that was resistant at 0 degrees C to the neutral detergent Triton X-100 but was disrupted by extraction of cholesterol with filipin or methyl-beta-cyclodextrin. In contrast, the CXCR4 chemokine receptor, a coreceptor for X4 strains of human immunodeficiency virus type 1 (HIV-1), was almost completely excluded from the detergent-resistant raft fraction. Accordingly, as determined by immunofluorescence with confocal microscopy, CD4 and CXCR4 did not coaggregate into antibody-induced cell surface patches or into patches of CXCR4 that formed naturally at the ruffled edges of adherent cells. The CXCR4 fluorescent patches were extracted with cold 1% Triton X-100, whereas the CD4 patches were resistant. In stringent support of these data, CD4 colocalized with patches of cholera toxin bound to the raft-associated sphingoglycolipid GM1, whereas CXCR4 did not. Addition of the CXCR4-activating chemokine SDF-1 alpha did not induce CXCR4 movement into rafts. Moreover, binding of purified monomeric gp120 envelope glycoproteins from strains of HIV-1 that use this coreceptor did not stimulate detectable redistributions of CD4 or CXCR4 between their separate membrane domains. However, adsorption of multivalent gp120-containing HIV-1 virion particles appeared to destabilize the local CD4-containing rafts. Indeed, adsorbed HIV-1 virions were detected by immunofluorescence microscopy and were almost all situated in nonraft regions of the cell surface. We conclude that HIV-1 initially binds to CD4 in a raft domain and that its secondary associations with CXCR4 require shifts of proteins and associated lipids away from their preferred lipid microenvironments. Our evidence suggests that these changes in protein-lipid interactions destabilize the plasma membrane microenvironment underlying the virus by at least several kilocalories per mole, and we propose that this makes an important contribution to fusion of the viral and cellular membranes during infection. Thus, binding of HIV-1 may be favored by the presence of CD4 in rafts, but the rafts may then disperse prior to the membrane fusion reaction.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11799176      PMCID: PMC135872          DOI: 10.1128/jvi.76.4.1802-1815.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  50 in total

Review 1.  Structure and function of sphingolipid- and cholesterol-rich membrane rafts.

Authors:  D A Brown; E London
Journal:  J Biol Chem       Date:  2000-06-09       Impact factor: 5.157

2.  Interaction of influenza virus haemagglutinin with sphingolipid-cholesterol membrane domains via its transmembrane domain.

Authors:  P Scheiffele; M G Roth; K Simons
Journal:  EMBO J       Date:  1997-09-15       Impact factor: 11.598

3.  CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5.

Authors:  A Trkola; T Dragic; J Arthos; J M Binley; W C Olson; G P Allaway; C Cheng-Mayer; J Robinson; P J Maddon; J P Moore
Journal:  Nature       Date:  1996-11-14       Impact factor: 49.962

4.  CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5.

Authors:  L Wu; N P Gerard; R Wyatt; H Choe; C Parolin; N Ruffing; A Borsetti; A A Cardoso; E Desjardin; W Newman; C Gerard; J Sodroski
Journal:  Nature       Date:  1996-11-14       Impact factor: 49.962

Review 5.  Functional rafts in cell membranes.

Authors:  K Simons; E Ikonen
Journal:  Nature       Date:  1997-06-05       Impact factor: 49.962

6.  The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes.

Authors:  C C Bleul; L Wu; J A Hoxie; T A Springer; C R Mackay
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-04       Impact factor: 11.205

7.  Binding of HIV-1 to its receptor induces tyrosine phosphorylation of several CD4-associated proteins, including the phosphatidylinositol 3-kinase.

Authors:  G Briand; B Barbeau; M Tremblay
Journal:  Virology       Date:  1997-02-17       Impact factor: 3.616

8.  Cytosolic Gag p24 as an index of productive entry of human immunodeficiency virus type 1.

Authors:  V Maréchal; F Clavel; J M Heard; O Schwartz
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

9.  Infectious properties of human immunodeficiency virus type 1 mutants with distinct affinities for the CD4 receptor.

Authors:  E J Platt; N Madani; S L Kozak; D Kabat
Journal:  J Virol       Date:  1997-02       Impact factor: 5.103

10.  Differences in CD4 dependence for infectivity of laboratory-adapted and primary patient isolates of human immunodeficiency virus type 1.

Authors:  D Kabat; S L Kozak; K Wehrly; B Chesebro
Journal:  J Virol       Date:  1994-04       Impact factor: 5.103

View more
  51 in total

1.  Anergy in CD4 memory T lymphocytes. II. Abrogation of TCR-induced formation of membrane signaling complexes.

Authors:  William T Lee; Aparna Prasad; Andrew R O Watson
Journal:  Cell Immunol       Date:  2012-05-19       Impact factor: 4.868

2.  Human immunodeficiency virus type 1 enters brain microvascular endothelia by macropinocytosis dependent on lipid rafts and the mitogen-activated protein kinase signaling pathway.

Authors:  Nancy Q Liu; Albert S Lossinsky; Waldemar Popik; Xia Li; Chandrasekhar Gujuluva; Benjamin Kriederman; Jaclyn Roberts; Tatania Pushkarsky; Michael Bukrinsky; Marlys Witte; Martin Weinand; Milan Fiala
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

3.  Specific association of glycoprotein B with lipid rafts during herpes simplex virus entry.

Authors:  Florent C Bender; J Charles Whitbeck; Manuel Ponce de Leon; Huan Lou; Roselyn J Eisenberg; Gary H Cohen
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

4.  Surface masking shapes the traffic of the neuropeptide Y Y2 receptor.

Authors:  Michael S Parker; Renu Sah; Steven L Parker
Journal:  Peptides       Date:  2012-06-23       Impact factor: 3.750

5.  Restricted lateral mobility of plasma membrane CD4 impairs HIV-1 envelope glycoprotein mediated fusion.

Authors:  Satinder S Rawat; Christina Zimmerman; Benitra T Johnson; Edward Cho; Stephen J Lockett; Robert Blumenthal; Anu Puri
Journal:  Mol Membr Biol       Date:  2008-01       Impact factor: 2.857

6.  Hedgehog threads to spread.

Authors:  James Briscoe; Jean-Paul Vincent
Journal:  Nat Cell Biol       Date:  2013-11       Impact factor: 28.824

7.  Rapid dissociation of HIV-1 from cultured cells severely limits infectivity assays, causes the inactivation ascribed to entry inhibitors, and masks the inherently high level of infectivity of virions.

Authors:  Emily J Platt; Susan L Kozak; James P Durnin; Thomas J Hope; David Kabat
Journal:  J Virol       Date:  2009-12-30       Impact factor: 5.103

8.  New cholesterol-specific antibodies remodel HIV-1 target cells' surface and inhibit their in vitro virus production.

Authors:  Zoltán Beck; Andrea Balogh; Andrea Kis; Emese Izsépi; László Cervenak; Glória László; Adrienn Bíró; Károly Liliom; Gábor Mocsár; György Vámosi; George Füst; Janos Matko
Journal:  J Lipid Res       Date:  2009-08-04       Impact factor: 5.922

9.  Ceramide, a target for antiretroviral therapy.

Authors:  Catherine M Finnegan; Satinder S Rawat; Anu Puri; Ji Ming Wang; Francis W Ruscetti; Robert Blumenthal
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-15       Impact factor: 11.205

10.  Evolution of CCR5 use before and during coreceptor switching.

Authors:  Mia Coetzer; Rebecca Nedellec; Janelle Salkowitz; Sherry McLaughlin; Yi Liu; Laura Heath; James I Mullins; Donald E Mosier
Journal:  J Virol       Date:  2008-09-24       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.